GB2025385A — Activated carbon and apparatus for hemoperfusion
Assigned to Sumitomo Chemical Co Ltd · Expires 1980-01-23 · 46y expired
What this patent protects
A method and apparatus for hemoperfusion comprising a vessel packed with a spherical active carbon having pores of substantially not larger than 500 ANGSTROM in radius, said spherical active carbon being produced by polymerising an ethylenically unsaturated aromatic compound, ma…
USPTO Abstract
A method and apparatus for hemoperfusion comprising a vessel packed with a spherical active carbon having pores of substantially not larger than 500 ANGSTROM in radius, said spherical active carbon being produced by polymerising an ethylenically unsaturated aromatic compound, making the resulting spherical polymer infusible, calcining the resulting infusible polymer and activating, and the use thereof. The apparatus is useful for the treatment of patients with chronic renal failure, acute intoxication, liver failure, hepatoreal syndrome or the like, particularly as an artificial kidney.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.